Roundview Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.56M Sell
51,517
-4,902
-9% -$338K 0.24% 99
2025
Q1
$3.92M Buy
56,419
+1,681
+3% +$117K 0.28% 83
2024
Q4
$4.71M Buy
54,738
+5,396
+11% +$464K 0.33% 71
2024
Q3
$5.88M Buy
49,342
+559
+1% +$66.6K 0.43% 56
2024
Q2
$6.96M Sell
48,783
-995
-2% -$142K 0.55% 40
2024
Q1
$6.39M Buy
49,778
+231
+0.5% +$29.7K 0.52% 45
2023
Q4
$5.13M Sell
49,547
-871
-2% -$90.1K 0.47% 49
2023
Q3
$4.59M Sell
50,418
-1,848
-4% -$168K 0.46% 53
2023
Q2
$4.23M Sell
52,266
-54
-0.1% -$4.37K 0.41% 59
2023
Q1
$4.16M Buy
52,320
+2,114
+4% +$168K 0.44% 64
2022
Q4
$3.4M Buy
50,206
+994
+2% +$67.3K 0.39% 75
2022
Q3
$2.45M Buy
49,212
+11,846
+32% +$590K 0.31% 88
2022
Q2
$2.08M Sell
37,366
-240
-0.6% -$13.4K 0.25% 105
2022
Q1
$2.09M Buy
37,606
+212
+0.6% +$11.8K 0.21% 117
2021
Q4
$2.09M Sell
37,394
-332
-0.9% -$18.6K 0.21% 123
2021
Q3
$1.81M Buy
37,726
+52
+0.1% +$2.5K 0.2% 128
2021
Q2
$1.58M Buy
37,674
+806
+2% +$33.8K 0.18% 136
2021
Q1
$1.24M Buy
36,868
+868
+2% +$29.3K 0.16% 146
2020
Q4
$1.26M Buy
36,000
+94
+0.3% +$3.28K 0.17% 135
2020
Q3
$1.25M Buy
35,906
+394
+1% +$13.7K 0.2% 119
2020
Q2
$1.16M Sell
35,512
-1,464
-4% -$47.9K 0.2% 119
2020
Q1
$1.11M Buy
36,976
+1,488
+4% +$44.8K 0.24% 114
2019
Q4
$1.03M Buy
35,488
+712
+2% +$20.6K 0.2% 137
2019
Q3
$899K Buy
34,776
+200
+0.6% +$5.17K 0.19% 138
2019
Q2
$882K Buy
34,576
+1,356
+4% +$34.6K 0.2% 131
2019
Q1
$869K Sell
33,220
-520
-2% -$13.6K 0.21% 126
2018
Q4
$777K Buy
33,740
+420
+1% +$9.67K 0.22% 119
2018
Q3
$785K Buy
33,320
+440
+1% +$10.4K 0.19% 135
2018
Q2
$758K Buy
32,880
+2,330
+8% +$53.7K 0.2% 134
2018
Q1
$752K Buy
30,550
+600
+2% +$14.8K 0.21% 127
2017
Q4
$804K Hold
29,950
0.21% 126
2017
Q3
$721K Sell
29,950
-29,986
-50% -$722K 0.21% 126
2017
Q2
$1.29M Buy
+59,936
New +$1.29M 0.37% 85